Human ILT2 receptor associates with murine MHC class I molecule in vivo and impairs T cell function

Siyuan Liang, Wie Zhang, Anatolij Horuzsko

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Immunoglobulin-like transcript 2 (ILT2/LILRB1/LIR1/CD85j) is an inhibitory receptor broadly expressed on leukocytes and antigen-presenting cells that recognizes HLA-class I and human cytomegalovirus UL18 proteins. The function of this receptor is to generate negative signals or to inhibit positive signals. Here, we demonstrate the model to study the function of ILT2 in vivo using a newly generated transgenic mouse expressing the human inhibitory receptor on T, B, NK, and NKT cells. ILT2 expression affects thymocyte development and targets the proximal TCR signaling pathway, resulting in long-term survival or acceptance of skin allografts. The phenotype and constitutive tyrosine phosphorylation of ILT2 in transgenic mice illustrate the possible existence of a murine ligand. We report here that H-2Db, a murine MHC class I molecule, associates with human ILT2 in vivo. This engagement with ILT2 directs effects on thymocyte development, negative regulation of TCR signaling, T cell activation, and alloimmune responses. Our finding provides support for an important inhibitory function of ILT2 in T cells in vivo and opens up strategies for targeting proximal TCR signaling for prevention of allograft rejection.

Original languageEnglish (US)
Pages (from-to)2457-2471
Number of pages15
JournalEuropean Journal of Immunology
Volume36
Issue number9
DOIs
StatePublished - Sep 1 2006

Fingerprint

Thymocytes
T-Lymphocytes
Transgenic Mice
Allografts
Natural Killer T-Cells
Antigen-Presenting Cells
HLA Antigens
Natural Killer Cells
Tyrosine
Immunoglobulins
B-Lymphocytes
Phosphorylation
Ligands
Phenotype
Skin
Survival
Human herpesvirus 1 VP23 protein

Keywords

  • Allograft survival
  • Inhibitory receptor
  • Ligand
  • Negative regulation
  • T cell activation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Human ILT2 receptor associates with murine MHC class I molecule in vivo and impairs T cell function. / Liang, Siyuan; Zhang, Wie; Horuzsko, Anatolij.

In: European Journal of Immunology, Vol. 36, No. 9, 01.09.2006, p. 2457-2471.

Research output: Contribution to journalArticle

@article{5241fb8ad8804b0fa9539b14d6822606,
title = "Human ILT2 receptor associates with murine MHC class I molecule in vivo and impairs T cell function",
abstract = "Immunoglobulin-like transcript 2 (ILT2/LILRB1/LIR1/CD85j) is an inhibitory receptor broadly expressed on leukocytes and antigen-presenting cells that recognizes HLA-class I and human cytomegalovirus UL18 proteins. The function of this receptor is to generate negative signals or to inhibit positive signals. Here, we demonstrate the model to study the function of ILT2 in vivo using a newly generated transgenic mouse expressing the human inhibitory receptor on T, B, NK, and NKT cells. ILT2 expression affects thymocyte development and targets the proximal TCR signaling pathway, resulting in long-term survival or acceptance of skin allografts. The phenotype and constitutive tyrosine phosphorylation of ILT2 in transgenic mice illustrate the possible existence of a murine ligand. We report here that H-2Db, a murine MHC class I molecule, associates with human ILT2 in vivo. This engagement with ILT2 directs effects on thymocyte development, negative regulation of TCR signaling, T cell activation, and alloimmune responses. Our finding provides support for an important inhibitory function of ILT2 in T cells in vivo and opens up strategies for targeting proximal TCR signaling for prevention of allograft rejection.",
keywords = "Allograft survival, Inhibitory receptor, Ligand, Negative regulation, T cell activation",
author = "Siyuan Liang and Wie Zhang and Anatolij Horuzsko",
year = "2006",
month = "9",
day = "1",
doi = "10.1002/eji.200636031",
language = "English (US)",
volume = "36",
pages = "2457--2471",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "9",

}

TY - JOUR

T1 - Human ILT2 receptor associates with murine MHC class I molecule in vivo and impairs T cell function

AU - Liang, Siyuan

AU - Zhang, Wie

AU - Horuzsko, Anatolij

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Immunoglobulin-like transcript 2 (ILT2/LILRB1/LIR1/CD85j) is an inhibitory receptor broadly expressed on leukocytes and antigen-presenting cells that recognizes HLA-class I and human cytomegalovirus UL18 proteins. The function of this receptor is to generate negative signals or to inhibit positive signals. Here, we demonstrate the model to study the function of ILT2 in vivo using a newly generated transgenic mouse expressing the human inhibitory receptor on T, B, NK, and NKT cells. ILT2 expression affects thymocyte development and targets the proximal TCR signaling pathway, resulting in long-term survival or acceptance of skin allografts. The phenotype and constitutive tyrosine phosphorylation of ILT2 in transgenic mice illustrate the possible existence of a murine ligand. We report here that H-2Db, a murine MHC class I molecule, associates with human ILT2 in vivo. This engagement with ILT2 directs effects on thymocyte development, negative regulation of TCR signaling, T cell activation, and alloimmune responses. Our finding provides support for an important inhibitory function of ILT2 in T cells in vivo and opens up strategies for targeting proximal TCR signaling for prevention of allograft rejection.

AB - Immunoglobulin-like transcript 2 (ILT2/LILRB1/LIR1/CD85j) is an inhibitory receptor broadly expressed on leukocytes and antigen-presenting cells that recognizes HLA-class I and human cytomegalovirus UL18 proteins. The function of this receptor is to generate negative signals or to inhibit positive signals. Here, we demonstrate the model to study the function of ILT2 in vivo using a newly generated transgenic mouse expressing the human inhibitory receptor on T, B, NK, and NKT cells. ILT2 expression affects thymocyte development and targets the proximal TCR signaling pathway, resulting in long-term survival or acceptance of skin allografts. The phenotype and constitutive tyrosine phosphorylation of ILT2 in transgenic mice illustrate the possible existence of a murine ligand. We report here that H-2Db, a murine MHC class I molecule, associates with human ILT2 in vivo. This engagement with ILT2 directs effects on thymocyte development, negative regulation of TCR signaling, T cell activation, and alloimmune responses. Our finding provides support for an important inhibitory function of ILT2 in T cells in vivo and opens up strategies for targeting proximal TCR signaling for prevention of allograft rejection.

KW - Allograft survival

KW - Inhibitory receptor

KW - Ligand

KW - Negative regulation

KW - T cell activation

UR - http://www.scopus.com/inward/record.url?scp=33748868653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748868653&partnerID=8YFLogxK

U2 - 10.1002/eji.200636031

DO - 10.1002/eji.200636031

M3 - Article

C2 - 16897816

AN - SCOPUS:33748868653

VL - 36

SP - 2457

EP - 2471

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 9

ER -